Ralph Henry of InterveXion to Lead UA Contingent at SEC Symposium
Ralph Henry, a researcher at the University of Arkansas and co-founder of Innovate Arkansas client firm InterveXion Therapeutics, will be one of five UA innovators at the third-annual Southeastern Conference Symposium.